TerrAscend (OTCMKTS:TSNDF) is a vertically integrated cannabis company that operates across cultivation, processing and retailing in North America. The company’s business model spans seed-to-sale activities, enabling it to manage quality control, production efficiency and product innovation from its growing facilities through to its distribution networks. TerrAscend serves both adult-use and medical cannabis markets, offering a full suite of cannabis derivatives including dried flower, concentrates, vapes, edibles, tinctures and topicals.
Geographically, TerrAscend maintains operations in key regulated markets. In the United States, the company holds cultivation and processing facilities in Pennsylvania, New Jersey and Rhode Island, along with state-licensed dispensaries serving patients and adult consumers. In Canada, TerrAscend is active in Ontario through its production site and partnerships that support wholesale distribution to provincial retail channels. This cross-border footprint positions the company to capture demand in both established and emerging markets.
Product development is driven by an in-house research and development team focused on consistent potency, lab-tested safety and branded consumer experiences. TerrAscend’s portfolio includes proprietary brands designed to appeal to a range of consumer segments, from wellness-oriented tinctures to high-thc extracts and pre-rolled formats. The company also offers wholesale flower and bulk extracts to licensed operators and third-party distributors under supply agreements.
Founded in 2018, TerrAscend trades on the Canadian Securities Exchange under the symbol TER and on the OTC markets as TSNDF. Under the leadership of Chief Executive Officer Jason Wild, the company prioritizes compliance, operational excellence and strategic market entry. TerrAscend’s management team leverages extensive industry and financial expertise to navigate evolving regulatory frameworks and pursue growth through organic expansion and targeted acquisitions.
